Vitamin d vs. Valturna: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Vitamin d and Valturna. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 338,336 people who take Vitamin d and Valturna, and is updated regularly.
What is Vitamin d?
Vitamin d has active ingredients of ergocalciferol. It is often used in low vitamin d. eHealthMe is studying from 294,095 Vitamin d users. Check the latest studies of Vitamin d.
What is Valturna?
Valturna has active ingredients of aliskiren hemifumarate; valsartan. It is often used in high blood pressure. eHealthMe is studying from 619 Valturna users. Check the latest studies of Valturna.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
338,336 people who take Vitamin d and Valturna are studied.
Drugs being compared in this study:
- Valturna (aliskiren hemifumarate; valsartan)
- Vitamin D (ergocalciferol)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Vitamin D:
- not at all: 4.17 %
- somewhat: 20.74 %
- moderate: 35.37 %
- high: 29.71 %
- very high: 10.02 %
Valturna:
- not at all: 0 %
- somewhat: 28.57 %
- moderate: 28.57 %
- high: 28.57 %
- very high: 14.29 %
Want to compare Vitamin d with Valturna?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Vitamin d:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Valturna:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on ergocalciferol and aliskiren hemifumarate; valsartan (the active ingredients of Vitamin d and Valturna, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Symbicort cause Ankylosing Spondylitis? - 3 seconds ago
- Topamax and Not Effective for Girls aged 2-9 - 5 seconds ago
- Topamax and Drug Ineffective for Girls aged 2-9 - 5 seconds ago
- Mirapex and Colace drug interactions for women aged 50-59 - 14 seconds ago
- Pantoprazole and Neoplasm Malignant for Women aged 60+ - 25 seconds ago
- Could Provigil cause Restlessness Aggravated? - 28 seconds ago
- Olanzapine and Confusional State for Women aged 40-49 - 49 seconds ago
- Paracetamol and Pyrazinamide drug interactions for men aged 30-39 - 52 seconds ago
- Drug interactions of Pyridoxine Hydrochloride and Ferrous Fumarate - a minute ago
- Acute Lymphocytic Leukemia (All) and Cerebral Haemorrhage - a minute ago